Metabolic engineering is an interdisciplinary field of research that involves the manipulation of the metabolic pathways and processes of an organism in order to produce a desired product. It is an important tool for optimizing the yields of desired compounds and for the production of novel compounds with desirable properties. Metabolic engineering focuses on understanding the metabolic pathways and processes of an organism, and applies the knowledge to improve the metabolic process. This can be done through genetic engineering, which involves the introduction of genes with desired functions into the organism, or through bioprocess engineering, which involves the optimization of the biochemical reactions involved in the metabolic pathway. Metabolic engineering also employs techniques such as gene expression analysis, metabolic flux analysis, and other systems biology approaches to study and improve metabolic pathways. Metabolic engineering is utilized in many industries, such as the production of pharmaceuticals, food products, and chemicals for industrial uses. As the field of metabolic engineering advances, it will be possible to produce a variety of products with greater efficiency and at lower costs.
Title : Biovalorization of overripe banana (Musa spp.) extract as a functional ingredient for glycemic regulation in diabesity management
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title :
Valasia Iakovoglou, UNESCO chair Con-E-Ect, International Hellenic University, Greece
Title : The antimicrobial activity of six Ocimum species against human microbial pathogens
Srinivasa Rao Mentreddy, Alabama A&M University, United States
Title : Effect of climate and weather on plant biology and biotechnology
Vijayan Gurumurthy Iyer, Techno-Economic-Environmental Study and Check Consultancy Services, India
Title : Cambial rearrangement in cycads: First evidence from a basal seed plant lineage
Anna Ponce, Bethune-Cookman University, United States
Title : Utilizing plant derived extracellular vesicles for drug delivery and therapeutic development
Hillary Jean Pierre, Department of Pharmaceutics, United States